Principal Investigator
Izidore Lossos
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20231021
Clinical Trial Summary
A RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE III STUDY EVALUATING EFFICACY AND SAFETY OF MOSUNETUZUMAB IN COMBINATION WITH POLATUZUMAB VEDOTIN IN COMPARISON WITH RITUXIMAB IN COMBINATION WITH GEMCITABINE PLUS OXALIPLATIN IN PARTICIPANTS WITH RELAPSED OR REFRACTORY AGGRESSIVE B-CELL NON-HODGKINS LYMPHOMA
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2434624